Dosing Patterns and Treatment Costs of Erythropoietic Agents in Elderly Patients with Pre-Dialysis Chronic Kidney Disease in Managed Care Organisations

By Mei Sheng Duh  

Drugs & Aging, Vol. 23, Iss. 12, 2006-01 ,pp. : 969-976

Adis International

Access to resources Recommend Favorite

Population pharmacokinetics of darbepoetin alfa in peritoneal dialysis and non-dialysis patients with chronic kidney disease after single subcutaneous administration

By Kawakami Kazuki   Takama Hirotaka   Nakashima Daisuke   Tanaka Hideji   Uchida Eiji   Akizawa Tadao  

European Journal of Clinical Pharmacology, Vol. 65, Iss. 2, 2009-02 ,pp. : 169-178

Springer Publishing Company

Access to resources Recommend Favorite

A Review of the Costs and Cost Effectiveness of Interventions in Chronic Kidney Disease: Implications for Policy

By Menzin Joseph  

PharmacoEconomics, Vol. 29, Iss. 10, 2011-10 ,pp. : 839-861

Adis International

Access to resources Recommend Favorite

Antidiabetic Agents in Patients with Chronic Kidney Disease and End-Stage Renal Disease on Dialysis: Metabolism and Clinical Practice

By  

Current Drug Metabolism, Vol. 12, Iss. 1, 2011-01 ,pp. : 57-69

Bentham Science Publishers

Access to resources Recommend Favorite

Estimating `Costs' for Cost-Effectiveness Analysis

By Miners Alec  

PharmacoEconomics, Vol. 26, Iss. 9, 2008-01 ,pp. : 745-751

Adis International

Access to resources Recommend Favorite